New Dexcom continuous glucose monitor (CGM), the G6, in late 2018
Dexcom has announced that it plans to launch its new continuous glucose monitor (CGM), the G6, in late 2018.
Early data has shown the G6 to be the most accurate device the California-based tech company has released. One study involving 49 participants found the G6 collected 96 per cent of blood glucose readings within 20 mg/dl of the true glucose value.
The G6 will be one of the first products to emerge from Dexcom’s partnership with tech giant Verily (formerly Google Life Sciences).
It will feature a 10-day wear with just one fingerstick calibration per day. In comparison, Dexcom’s G4 and G5 devices both require twice-daily calibration.
Dexcom plans to submit the G6 for US Food and Drug Administration (FDA) approval later this year, with commercialisation the planned for the end of 2018.